Skip to main content
Erschienen in: Cancer Causes & Control 12/2014

01.12.2014 | Original paper

Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP Diet and Health Study

verfasst von: Geoffrey C. Kabat, Mimi Y. Kim, Albert R. Hollenbeck, Thomas E. Rohan

Erschienen in: Cancer Causes & Control | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To examine the association of adult height with risk of cancer at different anatomic sites in a cohort of men and women.

Methods

The association of self-reported height with subsequent cancer risk was assessed in 288,683 men and 192,514 women enrolled in the National Institutes of Health-AARP Diet and Health Study. After a median follow-up of 10.5 years, incident cancer was diagnosed in 51,139 men and 23,407 women. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95 % confidence intervals (95 % CIs) for the association of height with cancer risk.

Results

After adjustment for covariates, height was positively associated with increased risk of all cancers combined in both men [HR10 cm increase = 1.05 (95 % CI 1.04–1.06)] and women [HR10 cm increase = 1.08 (95 % CI 1.06–1.10)]. Several sites common to men and women showed significant positive associations with height: colon, rectum, kidney, melanoma, and non-Hodgkin’s lymphoma. For other shared sites, the association differed by sex. For still other sites, there was no clear association with height. Positive associations were also observed with cancers of the breast, endometrium, and prostate.

Conclusions

Different patterns were observed in the height–cancer association by sex. Studies investigating the biological mechanisms underlying the association of height with cancer risk should focus on those sites that show a reproducible association with attained height.
Literatur
1.
Zurück zum Zitat Valaoras V, MacMahon B, Trichopoulos D, Polychronopoulou A (1969) Lactation and reproductive histories of breast cancer patients in Greater Athens, 1965–67. Int J Cancer 4:350–363PubMedCrossRef Valaoras V, MacMahon B, Trichopoulos D, Polychronopoulou A (1969) Lactation and reproductive histories of breast cancer patients in Greater Athens, 1965–67. Int J Cancer 4:350–363PubMedCrossRef
2.
Zurück zum Zitat De Waard F (1975) Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 35:3351–3356PubMed De Waard F (1975) Breast cancer incidence and nutritional status with particular reference to body weight and height. Cancer Res 35:3351–3356PubMed
3.
Zurück zum Zitat Albanes D, Jones DY, Schatzkin A, Micozzi MS, Taylor PR (1988) Adult stature and risk of cancer. Cancer Res 48:1658–1662PubMed Albanes D, Jones DY, Schatzkin A, Micozzi MS, Taylor PR (1988) Adult stature and risk of cancer. Cancer Res 48:1658–1662PubMed
4.
Zurück zum Zitat Swanson CA, Jones DY, Schatzkin A, Brinton LA, Ziegler RG (1988) Breast cancer assessed by anthropometry in the NHANES I epidemiologic follow-up study. Cancer Res 48:5363–5367PubMed Swanson CA, Jones DY, Schatzkin A, Brinton LA, Ziegler RG (1988) Breast cancer assessed by anthropometry in the NHANES I epidemiologic follow-up study. Cancer Res 48:5363–5367PubMed
5.
Zurück zum Zitat Albanes D, Taylor PR (1990) International differences in body height and weight and their relationship to cancer incidence. Nutr Cancer 14:69–77PubMedCrossRef Albanes D, Taylor PR (1990) International differences in body height and weight and their relationship to cancer incidence. Nutr Cancer 14:69–77PubMedCrossRef
6.
Zurück zum Zitat Hebert PR, Ajani U, Cook NR, Lee I-M, Chan KS, Hennekens CH (1997) Adult height and incidence of cancer in male physicians. Cancer Causes Control 8:591–597PubMedCrossRef Hebert PR, Ajani U, Cook NR, Lee I-M, Chan KS, Hennekens CH (1997) Adult height and incidence of cancer in male physicians. Cancer Causes Control 8:591–597PubMedCrossRef
7.
Zurück zum Zitat Batty GD, Shipley MJ, Langenberg C, Marmot MG, Davey Smith G (2006) Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study. Ann Oncol 17:157–166PubMedCrossRef Batty GD, Shipley MJ, Langenberg C, Marmot MG, Davey Smith G (2006) Adult height in relation to mortality from 14 cancer sites in men in London (UK): evidence from the original Whitehall study. Ann Oncol 17:157–166PubMedCrossRef
8.
Zurück zum Zitat Sung J, Song Y-M, Lawlor DA, Davey Smith G, Ebrahim S (2009) Height and site-specific cancer risk: a cohort study of a Korean adult population. Am J Epidemiol 170:53–64PubMedCrossRef Sung J, Song Y-M, Lawlor DA, Davey Smith G, Ebrahim S (2009) Height and site-specific cancer risk: a cohort study of a Korean adult population. Am J Epidemiol 170:53–64PubMedCrossRef
9.
Zurück zum Zitat Batty GD, Barzi F, Woodward M, Jamrozik K, Woo J, Kim HC, Ueshima H, Huxley RR, Asia Pacific Cohort Studies Collaboration (2010) Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration. Ann Oncol 21:646–654PubMedCentralPubMedCrossRef Batty GD, Barzi F, Woodward M, Jamrozik K, Woo J, Kim HC, Ueshima H, Huxley RR, Asia Pacific Cohort Studies Collaboration (2010) Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration. Ann Oncol 21:646–654PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V (2011) Height and cancer incidence in the million women study: prospective cohort, and meta-analysis of prospective studies of height and total cancer. Lancet Oncol 12:785–794PubMedCentralPubMedCrossRef Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V (2011) Height and cancer incidence in the million women study: prospective cohort, and meta-analysis of prospective studies of height and total cancer. Lancet Oncol 12:785–794PubMedCentralPubMedCrossRef
11.
Zurück zum Zitat Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE (2012) Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 132:1125–1132PubMedCrossRef Kabat GC, Heo M, Kamensky V, Miller AB, Rohan TE (2012) Adult height in relation to risk of cancer in a cohort of Canadian women. Int J Cancer 132:1125–1132PubMedCrossRef
12.
Zurück zum Zitat The Emerging Risk Factors Collaboration (2012) Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 41:1419–1433PubMedCentralCrossRef The Emerging Risk Factors Collaboration (2012) Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. Int J Epidemiol 41:1419–1433PubMedCentralCrossRef
13.
Zurück zum Zitat Kabat GC, Anderson ML, Heo M, Hosgood HD III, Kamensky V, Bea JW, Hou L, Lane DS, Wactawski-Wende J, Manson JE, Rohan TE (2013) Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomark Prev 22:1353–1363CrossRef Kabat GC, Anderson ML, Heo M, Hosgood HD III, Kamensky V, Bea JW, Hou L, Lane DS, Wactawski-Wende J, Manson JE, Rohan TE (2013) Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomark Prev 22:1353–1363CrossRef
14.
Zurück zum Zitat Wiren S, Häggström C, Ulmer H, Manjer J, Bjørge T, Nagel G, Johansen D, Hallmans G, Engeland A, Concin H, Jonsson H, Selmer R, Tretli S, Stocks T, Stattin P (2014) Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 25:151–159PubMedCentralPubMedCrossRef Wiren S, Häggström C, Ulmer H, Manjer J, Bjørge T, Nagel G, Johansen D, Hallmans G, Engeland A, Concin H, Jonsson H, Selmer R, Tretli S, Stocks T, Stattin P (2014) Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control 25:151–159PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Walter RB, Brasky TM, Buckley SA, Potter JD, White E (2013) Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst 105:860–868PubMedCentralPubMedCrossRef Walter RB, Brasky TM, Buckley SA, Potter JD, White E (2013) Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst 105:860–868PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Park PH, Hoffmann K, Allen N, van Gils CH, Kahw K-T, Tehard B et al (2004) Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 111:762–771CrossRef Park PH, Hoffmann K, Allen N, van Gils CH, Kahw K-T, Tehard B et al (2004) Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 111:762–771CrossRef
17.
Zurück zum Zitat Pischon T, Lahmann PH, Boeing H, Tjønneland A, Halkjaer J, Overad K et al (2006) Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 118:728–738PubMedCrossRef Pischon T, Lahmann PH, Boeing H, Tjønneland A, Halkjaer J, Overad K et al (2006) Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 118:728–738PubMedCrossRef
18.
Zurück zum Zitat Lahmann PH, Cust AE, Friedenreich CM, Schultz M, Lukanova A, Kaaks R et al (2010) Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126:2404–2415PubMed Lahmann PH, Cust AE, Friedenreich CM, Schultz M, Lukanova A, Kaaks R et al (2010) Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 126:2404–2415PubMed
19.
Zurück zum Zitat Park JY, Mitrou PN, Keogh RH, Luben RN, Wareham NJ, Khaw K-T (2012) Self-reported and measured anthropometric data and risk of colorectal cancer in the EPIC-Norfolk study. Int J Obes 36:107–118CrossRef Park JY, Mitrou PN, Keogh RH, Luben RN, Wareham NJ, Khaw K-T (2012) Self-reported and measured anthropometric data and risk of colorectal cancer in the EPIC-Norfolk study. Int J Obes 36:107–118CrossRef
20.
Zurück zum Zitat Bjørge T, Engeland A, Tretli S, Weiderpass E (2006). Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 120:378–383 Bjørge T, Engeland A, Tretli S, Weiderpass E (2006). Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 120:378–383
21.
Zurück zum Zitat Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM (2001) Height, leg length, and cancer risk a systematic review. Epidemiol Rev 23:313–342PubMedCrossRef Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM (2001) Height, leg length, and cancer risk a systematic review. Epidemiol Rev 23:313–342PubMedCrossRef
22.
Zurück zum Zitat Albanes D, Winick M (1988) Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst 80:772–774PubMedCrossRef Albanes D, Winick M (1988) Are cell number and cell proliferation risk factors for cancer? J Natl Cancer Inst 80:772–774PubMedCrossRef
23.
Zurück zum Zitat Trichopoulos D, Lipworth L (1995) Is cancer causation simpler than we thought, but more intractable? Epidemiology 6:347–349PubMedCrossRef Trichopoulos D, Lipworth L (1995) Is cancer causation simpler than we thought, but more intractable? Epidemiology 6:347–349PubMedCrossRef
24.
Zurück zum Zitat Batty GD, Shipley MJ, Gunnell D, Huxley R, Kivimaki M, Woodward M, Lee CM, Smith GD (2009) Height, wealth, and health: an overview with new data from three longitudinal studies. Econ Hum Biol 7:137–152PubMedCrossRef Batty GD, Shipley MJ, Gunnell D, Huxley R, Kivimaki M, Woodward M, Lee CM, Smith GD (2009) Height, wealth, and health: an overview with new data from three longitudinal studies. Econ Hum Biol 7:137–152PubMedCrossRef
25.
Zurück zum Zitat Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions. Am J Epidemiol 154:1119–1125PubMedCrossRef Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollenbeck AR, Hurwitz PE, Coyle L, Schussler N, Michaud DS, Freedman LS, Brown CC, Midthune D, Kipnis V (2001) Design and serendipity in establishing a large cohort with wide dietary intake distributions. Am J Epidemiol 154:1119–1125PubMedCrossRef
26.
Zurück zum Zitat Subar AF, Midthune D, Kulldorff M, Brown CC, Thompson FE, Kipnis V, Schatzkin A (2000) Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol 152:279–286PubMedCrossRef Subar AF, Midthune D, Kulldorff M, Brown CC, Thompson FE, Kipnis V, Schatzkin A (2000) Evaluation of alternative approaches to assign nutrient values to food groups in food frequency questionnaires. Am J Epidemiol 152:279–286PubMedCrossRef
27.
Zurück zum Zitat Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan L, Kipnis V, Schatzkin A (2005) Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIHAARP diet and health study. J Regist Manag 32:70–75 Michaud DS, Midthune D, Hermansen S, Leitzmann M, Harlan L, Kipnis V, Schatzkin A (2005) Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIHAARP diet and health study. J Regist Manag 32:70–75
28.
Zurück zum Zitat Valeri L, VanderWeele TJ (2013) Mediation analysis allowing for exposure–mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods 18:137–150PubMedCentralPubMedCrossRef Valeri L, VanderWeele TJ (2013) Mediation analysis allowing for exposure–mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods 18:137–150PubMedCentralPubMedCrossRef
29.
Zurück zum Zitat Wadsworth ME, Hardy RJ, Paul AA, Marshall SF, Cole TJ (2002) Leg and trunk length at 43 years in relation to childhood health, diet, and family circumstance: evidence from the 1946 national birth cohort. Int J Epidemiol 31:383–390PubMedCrossRef Wadsworth ME, Hardy RJ, Paul AA, Marshall SF, Cole TJ (2002) Leg and trunk length at 43 years in relation to childhood health, diet, and family circumstance: evidence from the 1946 national birth cohort. Int J Epidemiol 31:383–390PubMedCrossRef
30.
Zurück zum Zitat Berkey CS, Colditz GA, Rockett RH, Frazier AL, Willett WC (2009) Dairy consumption and female height growth: prospective cohort study. Cancer Epidemiol Biomark Prev 18:1881–1887CrossRef Berkey CS, Colditz GA, Rockett RH, Frazier AL, Willett WC (2009) Dairy consumption and female height growth: prospective cohort study. Cancer Epidemiol Biomark Prev 18:1881–1887CrossRef
31.
Zurück zum Zitat Ben Slomo Y, Holly J, McCarthy A, Savage P, Davies D, Gunnell D, Davey Smith G (2003) An investigation of fetal, postnatal and childhood growth with insulin-like growth factor 1 and binding protein 3 in adulthood. Clin Endocrinol (Oxf) 59:366–373CrossRef Ben Slomo Y, Holly J, McCarthy A, Savage P, Davies D, Gunnell D, Davey Smith G (2003) An investigation of fetal, postnatal and childhood growth with insulin-like growth factor 1 and binding protein 3 in adulthood. Clin Endocrinol (Oxf) 59:366–373CrossRef
32.
Zurück zum Zitat Martin RM, Holly JM, Gunnell D (2011) Milk and linear growth: programming of the IGF-I axis and implication for health in adulthood. In: Clemens RA, Hernell O, Michaelsen KF (eds), Milk and milk products in human nutrition. Nestle Nutrition Institute Workship Series: Pediatric Prorgram. vol 67. Nestec Ltd., Vevey/S. Karger AG, Basel, Switzerland; 2011, p 79–97 Martin RM, Holly JM, Gunnell D (2011) Milk and linear growth: programming of the IGF-I axis and implication for health in adulthood. In: Clemens RA, Hernell O, Michaelsen KF (eds), Milk and milk products in human nutrition. Nestle Nutrition Institute Workship Series: Pediatric Prorgram. vol 67. Nestec Ltd., Vevey/S. Karger AG, Basel, Switzerland; 2011, p 79–97
33.
Zurück zum Zitat Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Naor D, De Meyts P (1997) Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 40(Suppl 2):S25–S31PubMedCrossRef Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Naor D, De Meyts P (1997) Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 40(Suppl 2):S25–S31PubMedCrossRef
34.
Zurück zum Zitat Gooch JL, Van Den Berg CL, Yee D (1999) Insulin‐like growth factor (IGF)‐1 rescues breast cancer cells from chemotherapy‐induced cell death—proliferative and anti‐apoptotic effects. Breast Cancer Res Treat 56:1–10 Gooch JL, Van Den Berg CL, Yee D (1999) Insulin‐like growth factor (IGF)‐1 rescues breast cancer cells from chemotherapy‐induced cell death—proliferative and anti‐apoptotic effects. Breast Cancer Res Treat 56:1–10
35.
Zurück zum Zitat McAdams MA, Van Dam RM, Hu FB (2007) Comparison of self-reported and measured BMI as correlates of disease markers in US Adults. Obesity 15:188–196PubMedCrossRef McAdams MA, Van Dam RM, Hu FB (2007) Comparison of self-reported and measured BMI as correlates of disease markers in US Adults. Obesity 15:188–196PubMedCrossRef
36.
Zurück zum Zitat Spencer EA, Appleby PN, Davey GK, Key TJ (2002) Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 5:561–565PubMedCrossRef Spencer EA, Appleby PN, Davey GK, Key TJ (2002) Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 5:561–565PubMedCrossRef
37.
Zurück zum Zitat Siemiaticki J, Richardson L, Boffetta P (2006) Occupation (Chapt. 18). In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York Siemiaticki J, Richardson L, Boffetta P (2006) Occupation (Chapt. 18). In: Schottenfeld D, Fraumeni JF Jr (eds) Cancer epidemiology and prevention, 3rd edn. Oxford University Press, New York
Metadaten
Titel
Attained height, sex, and risk of cancer at different anatomic sites in the NIH-AARP Diet and Health Study
verfasst von
Geoffrey C. Kabat
Mimi Y. Kim
Albert R. Hollenbeck
Thomas E. Rohan
Publikationsdatum
01.12.2014
Verlag
Springer International Publishing
Erschienen in
Cancer Causes & Control / Ausgabe 12/2014
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-014-0476-1

Weitere Artikel der Ausgabe 12/2014

Cancer Causes & Control 12/2014 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.